Compile Data Set for Download or QSAR
maximum 50k data
Found 49 Enz. Inhib. hit(s) with all data for entry = 10332
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528405(5-(4-Chloro-3-methoxyphenyl)-2-(4-chlorophenyl)-[1...)
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528519(5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-benzyl-[1,2,4...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528477(5-(Benzo[d][1,3]dioxol-5-yl)-2-(4-chlorophenyl)-[1...)
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528478(5-(2-Methoxyphenyl)-2-phenyl-[1,2,4]triazolo[1,5-a...)
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528479(2,5-Diphenyl-[1,2,4]triazolo[1,5-a]pyrimidin-7(4H)...)
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528480(5-(4-Methoxyphenyl)-2-phenyl-[1,2,4]triazolo[1,5-a...)
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528481(5-(3-Methoxyphenyl)-2-phenyl-[1,2,4]triazolo[1,5-a...)
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528482(2-(4-Chlorophenyl)-5-(4-methoxyphenyl)-[1,2,4]tria...)
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528483(2-(4-Methoxyphenyl)-5-phenyl-[1,2,4]triazolo[1,5-a...)
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528484(2-(2-Chlorophenyl)-5-phenyl-[1,2,4]triazolo[1,5-a]...)
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528485(5-(3,4-Dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]pyri...)
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528486(5-(4-Methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidi...)
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528487(5-(Benzo[d][1,3]dioxol-5-yl)-2-benzyl-[1,2,4]triaz...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528488(5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-(pyridin-2-yl...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528489(5-(1H-Indazol-5-yl)-2-(pyridin-2-yl)-[1,2,4]triazo...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528490(5-(1H-indazol-5-yl)-2-methyl-[1,2,4]triazolo[1,5-a...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528491(2-Ethyl-5-(1H-indazol-5-yl)-[1,2,4]triazolo[1,5-a]...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528492(5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-ethyl-[1,2,4]...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528493(5-(1H-Benzo[d][1,2,3]triazol-5-yl)-N-methyl-7-oxo-...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528405(5-(4-Chloro-3-methoxyphenyl)-2-(4-chlorophenyl)-[1...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528476(5-(4-Chloro-3-methoxyphenyl)-2-(4-fluorophenyl)-[1...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528494(2-(3,4-Dichlorophenyl)-5-(1H-indazol-5-yl)-[1,2,4]...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528495(5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-(3,4-dichloro...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528496(2-(3-Chlorophenyl)-5-(1H-indazol-5-yl)-[1,2,4]tria...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528497(5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-(3-chlorophen...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528498(5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-isopropyl-[1,...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528477(5-(Benzo[d][1,3]dioxol-5-yl)-2-(4-chlorophenyl)-[1...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528499(5-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-methyl-[...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528500(5-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-[1,2,4]tri...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528501(2-Benzyl-5-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-[...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528502(2-Benzyl-5-(4-methoxyphenyl)-[1,2,4]triazolo[1,5-a...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528503(2-(4-Fluorophenyl)-5-(1H-indazol-5-yl)-[1,2,4]tria...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528504(5-(1-Ethyl-1H-indazol-5-yl)-2-(4-fluorophenyl)-[1,...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528505(5-(1H-Benzo[d][1,2,3]triazol-6-yl)-2-(2-chlorophen...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528506(5-(1H-benzo[d][1,2,3]triazol-6-yl)-2-o-tolyl-[1,2,...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528507(5-(1H-benzo[d][1,2,3]triazol-6-yl)-7-oxo-4,7-dihyd...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528508(US11191765, Example 25)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528486(5-(4-Methoxyphenyl)-[1,2,4]triazolo[1,5-a]pyrimidi...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528510(5-(4-Methoxyphenyl)-2-methyl-[1,2,4]triazolo[1,5-a...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528511(5-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-(pyridin...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528512(5-(Benzo[d][1,3]dioxol-5-yl)-2-(pyridin-2-yl)-[1,2...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528482(2-(4-Chlorophenyl)-5-(4-methoxyphenyl)-[1,2,4]tria...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528513(5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-(4-chlorophen...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528514(5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-(4-fluorophen...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528515(5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-phenyl-[1,2,4...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528516(2-(4-Chlorophenyl)-5-(1-ethyl-1H-indazol-5-yl)-[1,...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528517(5-(1H-Benzo[d][1,2,3]triazol-5-yl)-2-methyl-[1,2,4...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528518(2-(4-Chlorophenyl)-5-(1H-indazol-5-yl)-[1,2,4]tria...)
Affinity DataIC50: <1.00E+4nMAssay Description:The aim of the FRET assay is to determine the inhibition potential of test compounds on targeted kinase. This assay platform provides a homogenous sc...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPAS domain-containing serine/threonine-protein kinase(Homo sapiens (Human))
Bioenergenix

US Patent
LigandPNGBDBM528476(5-(4-Chloro-3-methoxyphenyl)-2-(4-fluorophenyl)-[1...)
Affinity DataIC50: <1.00E+4nMAssay Description:Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) is...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent